Starting Friday, Americans can order the nasal spray flu vaccine online and have it shipped directly to their home.

AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important milestone for easier access to vaccinations in 34 U.S. states. This initiative likely contributed to its stock price increase of 12% last quarter,

AstraZeneca PLC released its flu vaccine nasal spray for at-home use on Friday, an option that comes at a contentious time for vaccine access in the US.

AstraZeneca introduces FluMist Home, offering a needle-free flu vaccine delivered directly to your door. This FDA-approved nasal spray allows adults aged 18-49 and parents of children aged 2-17 to administer the vaccine at home,

AstraZeneca's FluMist, which has the Food and Drug Administration approval, can now be home-delivered to people in 34 states under the brand name "FluMist home."